2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Hepatocellular Carcinoma J HEPATOCELL CARCINO (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.2
51人评分
我要评分
声誉 8.7 影响力 5.6 速度 9.6 | |||||||||||
期刊ISSN | 2253-5969 | 微信扫码收藏此期刊 | ||||||||||
2022-2023最新影响因子 (数据来源于搜索引擎) | 4.1 点击查看影响因子趋势图 | |||||||||||
实时影响因子 | 截止2024年3月26日:4.198 | |||||||||||
2022-2023自引率 | 2.40%点击查看自引率趋势图 | |||||||||||
五年影响因子 | 4.3 | |||||||||||
h-index | 暂无h-index数据 | |||||||||||
CiteScore | 暂无CiteScore数据 | |||||||||||
期刊简介 |
| |||||||||||
期刊官方网站 | http://www.dovepress.com/journal-of-hepatocellular-carcinoma-journal | |||||||||||
期刊投稿网址 | ||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Journal of Hepatocellular Carcinoma的语言要求,还能让Journal of Hepatocellular Carcinoma编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Journal of Hepatocellular Carcinoma编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||
是否OA开放访问 | Yes | |||||||||||
OA期刊相关信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:hepatocellular carcinoma、cancer、liver cancer、hepatitis b virus 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||
通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||
出版商 | DOVE MEDICAL PRESS LTD | |||||||||||
涉及的研究方向 | ONCOLOGY- | |||||||||||
出版国家或地区 | NEW ZEALAND | |||||||||||
出版语言 | English | |||||||||||
出版周期 | ||||||||||||
出版年份 | 0 | |||||||||||
年文章数 | 96点击查看年文章数趋势图 | |||||||||||
Gold OA文章占比 | 89.29% | |||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 79.17% | |||||||||||
WOS期刊SCI分区 ( 2022-2023年最新版) | WOS分区等级:2区
| |||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||
中科院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中科院SCI期刊分区趋势图
| |||||||||||
中科院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||
中科院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Directory of Open Access Journals (DOAJ) | |||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2253-5969%5BISSN%5D | |||||||||||
平均审稿速度 | 网友分享经验: 16 Weeks | |||||||||||
平均录用比例 | 网友分享经验: | |||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 | |||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Journal of Hepatocellular Carcinoma顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance Author: Zou, Xinhua; Xu, Qingyu; You, Ran; Yin, Guowen Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 267-279. DOI: 10.2147/JHC.S399874Journalof PubMed DOI |
2. | Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Carcinoma Author: Zhou, Cheng; Yang, Zhang-Fu; Sun, Bao-Ye; Yi, Yong; Wang, Zheng; Zhou, Jian; Fan, Jia; Gan, Wei; Ren, Ning; Qiu, Shuang-Jian Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 697-712. DOI: 10.2147/JHC.S401639 PubMed DOI |
3. | Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus Author: Zhao, Xiao-Hui; Li, Hai-Liang; Guo, Chen-Yang; Yao, Quan-Jun; Xia, Wei-Li; Hu, Hong-Tao Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 231-240. DOI: 10.2147/JHC.S392293 PubMed DOI |
4. | Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma Author: Zhang, Yuyuan; Liu, Zaoqu; Li, Jie; Li, Xin; Duo, Mengjie; Weng, Siyuan; Lv, Peijie; Jiang, Guozhong; Wang, Caihong; Li, Yan; Liu, Shichao; Li, Zhen Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 241-255. DOI: 10.2147/JHC.S398431 PubMed DOI |
5. | Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic B Patients Author: Zhang, Xingxin; Gu, Chenjian; Wei, Qian; Cao, Yirong; She, Weimin; Shi, Hong; Xie, Youhua; Guo, Jinsheng Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 599-609. DOI: 10.2147/JHC.S373333 PubMed DOI |
6. | Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma Author: Zhang, Xialu; Zhang, Chenguang; Zhao, Qingfang; Wang, Shanshan; Wang, Liyong; Si, Yang; Su, Qiang; Cheng, Shan; Ding, Wei Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 553-571. DOI: 10.2147/JHC.S400989Journalof PubMed DOI |
7. | Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis Author: Yang, Xuegang; Deng, Heping; Sun, Yanyuan; Zhang, Yi; Lu, Yujie; Xu, Guohui; Huang, Xiaoqi Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 303-313. DOI: 10.2147/JHC.S399135 PubMed DOI |
8. | Quantitative Assessment of Hypovascular Component in Arterial Phase to Help the Discrimination of Combined Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Author: Yang, Xue; Chang, Jing; Li, Ruili; Qi, Yu; Zeng, Xufen; Wang, Wei; Li, Hongjun Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 113-122. DOI: 10.2147/JHC.S390820 PubMed DOI |
9. | Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients Author: Yang, Chengkai; Wu, Xiaoya; Liu, Jianyong; Wang, Huaxiang; Jiang, Yi; Wei, Zhihong; Cai, Qiucheng Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 43-55. DOI: 10.2147/JHC.S396433 PubMed DOI |
10. | Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis Author: Xu, Junxiu; Zhang, Kai; Zhang, Genhao Journal: JOURNAL OF HEPATOCELLULAR CARCINOMA. 2023; Vol. 10, Issue , pp. 459-472. DOI: 10.2147/JHC.S401338 PubMed DOI |
|
|
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共2条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451